A Pilot Study of Ultra Rapid Opioid Rotation and Titration of Oxymorphone
NCT00945919 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12
Last updated 2009-07-24
Summary
This project will explore the safety and feasibility of performing a successful intravenous patient controlled analgesia (IV PCA) Oxymorphone titration and conversion to oral ER Oxymorphone (extended release or OPANA ER) in the outpatient setting.
Conditions
- Chronic Nociceptive Pain
- Neuropathic Pain
- Non-cancer Pain
Interventions
- DRUG
-
Oxymorphone ER
Rapid Opioid rotation/titration
Sponsors & Collaborators
-
Endo Pharmaceuticals
collaborator INDUSTRY -
Icahn School of Medicine at Mount Sinai
lead OTHER
Principal Investigators
-
Marco Pappagallo, MD · Icahn School of Medicine at Mount Sinai
Study Design
- Allocation
- NA
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-07-31
- Primary Completion
- 2010-12-31
- Completion
- 2011-05-31
Countries
- United States
Study Locations
More Related Trials
-
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
NCT00765856 ·Status: TERMINATED ·Phase: PHASE3
-
The Effects of Patient Features on Opioid Induced End-Tidal CO2
NCT01371903 ·Status: COMPLETED
-
Narcotic-Free Percutaneous Nephrolithotomy
NCT05924165 ·Status: COMPLETED ·Phase: PHASE4
-
To Demonstrate Equivalence in Analgesic Efficacy & Bowel Function Between OXN PR Higher Dose & Lower Dose Tablet Strengths in Subjects With Non-cancer or Cancer Pain
NCT02321397 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety, Tolerability, Effectiveness, and Pharmacokinetic Data in Opioid-experienced Children
NCT04681027 ·Status: SUSPENDED ·Phase: PHASE3
-
Effectiveness, Safety, and Tolerability Study of Oxymorphone Immediate Release (IR) Oral Liquid in Post Surgical Pediatric Subjects
NCT01210352 ·Status: COMPLETED ·Phase: PHASE3
-
Opioid-Sparing and Pain-Reducing Properties of Syntocinon: A Dose-Effect Determination
NCT04218409 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Open Label, Safety Study of EN3270 in Patients With Moderate to Severe Non-malignant, Chronic Pain
NCT00485225 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of ECMO on the Pharmacokinetics of the Drugs and Their Clinical Efficacy
NCT03659513 ·Status: COMPLETED
-
Optimizing Subcutaneous FEntanyl titRation: RApid Achievement of Adequate Exposure When Treating Cancer-Related paIn.
NCT06498037 ·Status: RECRUITING ·Phase: PHASE4
-
A Study of the Effectiveness and Safety of Sustained-release Hydromorphone (a Strong Opioid) in Patients With Chronic Noncancer Pain.
NCT00261495 ·Status: COMPLETED ·Phase: PHASE3
-
Montefiore Opioid and Pain Study
NCT03375645 ·Status: COMPLETED
-
Pharmacokinetic Study of Hydrocodone/APAP in Chronic Pain Patients
NCT01517295 ·Status: COMPLETED ·Phase: PHASE4
-
A Study on Oral and Intranasal Forms of Oxycodone in Healthy Volunteers Using Pharmacokinetic Modeling
NCT07223450 ·Status: COMPLETED ·Phase: PHASE1
-
Single-Dose PK Study of an Oxycodone/Acetaminophen Solution in Healthy Subjects
NCT02966860 ·Status: COMPLETED ·Phase: PHASE1
-
Titration of Intravenous Hydromorphone
NCT01892709 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetics And Relative Bioavailability Study Of Oxycodone in Healthy Volunteers
NCT01717027 ·Status: COMPLETED ·Phase: PHASE1
-
Dosing Intervals of Opioid Medication for Chronic Pain
NCT04132011 ·Status: WITHDRAWN ·Phase: PHASE4
-
Open-Label Safety and Tolerability Study of Oxymorphone for Acute Postoperative Pain in Pediatric Subjects.
NCT00801398 ·Status: COMPLETED ·Phase: PHASE3
-
OXY-2: The Pharmacogenetics of Oxycodone Analgesia in Human Experimental Pain Models
NCT00271973 ·Status: COMPLETED ·Phase: PHASE4
-
Oxycodone/Naloxone (OXN) Combination in Moderate to Severe Non-malignant Pain
NCT01167127 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Compare the Titration Efficacy and Safety of Control-released Oxycodone and Immediate-released Oxycodone in Patients With Moderate to Severe Cancer Pain
NCT03176199 ·Status: COMPLETED ·Phase: PHASE4
-
Inhaled vs IV Opioid Dosing for the Initial Treatment of Severe Acute Pain in the Emergency Department
NCT03257319 ·Status: COMPLETED ·Phase: PHASE3
-
Determination of Analgesic Equipotent Doses of Inhaled Metoxyflurane vs. Intravenous Fentanyl
NCT03894800 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetics of Fentanyl Following Intravenous and Oral Routes of Administration in Healthy Volunteers
NCT00714558 ·Status: COMPLETED ·Phase: PHASE1